$11.17
4.10% yesterday
Nasdaq, Sep 26, 10:00 pm CET
ISIN
US05368M1062
Symbol
CDMO

Avid Bioservices, Inc. Stock price

$11.17
+0.81 7.82% 1M
+4.38 64.51% 6M
+4.67 71.85% YTD
+1.16 11.59% 1Y
-10.08 47.44% 3Y
+5.91 112.16% 5Y
+1.23 12.37% 10Y
Nasdaq, Closing price Thu, Sep 26 2024
+0.44 4.10%
ISIN
US05368M1062
Symbol
CDMO
Sector

Key metrics

Market capitalization $712.59m
Enterprise Value $883.24m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 6.20
P/S ratio (TTM) P/S ratio 5.01
P/B ratio (TTM) P/B ratio 12.15
Revenue growth (TTM) Revenue growth -5.28%
Revenue (TTM) Revenue $142.36m
EBIT (operating result TTM) EBIT $-18.97m
Free Cash Flow (TTM) Free Cash Flow $-11.45m
Cash position $36.78m
EPS (TTM) EPS $-2.27
P/E forward negative
P/S forward 4.35
EV/Sales forward 5.40
Short interest 20.53%
Show more

Is Avid Bioservices, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.

Avid Bioservices, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a Avid Bioservices, Inc. forecast:

4x Buy
80%
1x Hold
20%

Analyst Opinions

5 Analysts have issued a Avid Bioservices, Inc. forecast:

Buy
80%
Hold
20%

Financial data from Avid Bioservices, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jul '24
+/-
%
142 142
5% 5%
100%
- Direct Costs 133 133
8% 8%
94%
8.93 8.93
66% 66%
6%
- Selling and Administrative Expenses 16 16
15% 15%
12%
- Research and Development Expense - -
-
-
-7.47 -7.47
206% 206%
-5%
- Depreciation and Amortization 12 12
39% 39%
8%
EBIT (Operating Income) EBIT -19 -19
1,485% 1,485%
-13%
Net Profit -144 -144
4,551% 4,551%
-101%

In millions USD.

Don't miss a Thing! We will send you all news about Avid Bioservices, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Avid Bioservices, Inc. Stock News

Neutral
GlobeNewsWire
15 days ago
TUSTIN, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that the company will participate in the upcoming Craig-Hallum Bi...
Neutral
Seeking Alpha
18 days ago
Avid Bioservices, Inc. (NASDAQ:CDMO ) Q1 2025 Earnings Conference Call September 9, 2024 4:30 PM ET Company Participants Tim Brons - IR, Vida Strategic Partners Nick Green - President and CEO Dan Hart - CFO Matt Kwietniak - Chief Commercial Officer Conference Call Participants Sean Dodge - RBC Capital Markets Matt Hewitt - Craig-Hallum Capital Group Paul Knight - KeyBanc Capital Markets Max Smo...
Neutral
GlobeNewsWire
18 days ago
-- Recorded First Quarter Revenue of $40.2 Million -- -- Signed $66 Million in Net New Business, Resulting in Backlog of $219 Million --
More Avid Bioservices, Inc. News

Company Profile

Avid Bioservices, Inc. engages in the commercial manufacturing which focuses on biopharmaceutical products derived from mammalian cell culture for culture for biotechnology and pharmaceutical companies. The firm specializes in clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory submissions, and support. The company was founded on June 3, 1981 and is headquartered in Tustin, CA.

Head office United States
CEO Nicholas Green
Employees 371
Founded 1981
Website avidbio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today